nodes	percent_of_prediction	percent_of_DWPC	metapath
Estradiol—CYP1A1—kidney cancer	0.121	0.653	CbGaD
Estradiol—ABCB1—kidney cancer	0.0646	0.347	CbGaD
Estradiol—NR1I2—Erlotinib—kidney cancer	0.0387	0.0719	CbGbCtD
Estradiol—NR1I2—Paclitaxel—kidney cancer	0.0354	0.0659	CbGbCtD
Estradiol—ABCC10—Gemcitabine—kidney cancer	0.0275	0.0512	CbGbCtD
Estradiol—ABCC10—Paclitaxel—kidney cancer	0.0249	0.0462	CbGbCtD
Estradiol—ABCC10—Vincristine—kidney cancer	0.0214	0.0399	CbGbCtD
Estradiol—UGT1A1—Pazopanib—kidney cancer	0.0179	0.0333	CbGbCtD
Estradiol—SLCO2B1—Erlotinib—kidney cancer	0.0171	0.0318	CbGbCtD
Estradiol—CYP1B1—Erlotinib—kidney cancer	0.0148	0.0275	CbGbCtD
Estradiol—SLCO1B3—Paclitaxel—kidney cancer	0.0139	0.0258	CbGbCtD
Estradiol—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.0138	0.0257	CbGbCtD
Estradiol—CYP3A7—Temsirolimus—kidney cancer	0.0138	0.0257	CbGbCtD
Estradiol—CYP1B1—Paclitaxel—kidney cancer	0.0135	0.0251	CbGbCtD
Estradiol—ABCC10—Doxorubicin—kidney cancer	0.0134	0.0249	CbGbCtD
Estradiol—UGT1A1—Erlotinib—kidney cancer	0.0128	0.0237	CbGbCtD
Estradiol—SLC22A3—Vincristine—kidney cancer	0.0127	0.0236	CbGbCtD
Estradiol—SLCO1B1—Pazopanib—kidney cancer	0.0124	0.023	CbGbCtD
Estradiol—UGT1A1—Sorafenib—kidney cancer	0.0104	0.0193	CbGbCtD
Estradiol—CYP3A5—Temsirolimus—kidney cancer	0.0104	0.0193	CbGbCtD
Estradiol—ABCG2—Pazopanib—kidney cancer	0.00983	0.0183	CbGbCtD
Estradiol—ABCG2—Dactinomycin—kidney cancer	0.00899	0.0167	CbGbCtD
Estradiol—SLC22A2—Vinblastine—kidney cancer	0.00763	0.0142	CbGbCtD
Estradiol—CYP1B1—Doxorubicin—kidney cancer	0.00728	0.0135	CbGbCtD
Estradiol—ABCG2—Erlotinib—kidney cancer	0.00701	0.0131	CbGbCtD
Estradiol—ABCB1—Temsirolimus—kidney cancer	0.00675	0.0126	CbGbCtD
Estradiol—CYP1A1—Erlotinib—kidney cancer	0.00648	0.012	CbGbCtD
Estradiol—ABCG2—Paclitaxel—kidney cancer	0.00642	0.0119	CbGbCtD
Estradiol—CYP3A4—Everolimus—kidney cancer	0.00599	0.0111	CbGbCtD
Estradiol—ABCG2—Sorafenib—kidney cancer	0.0057	0.0106	CbGbCtD
Estradiol—ABCG2—Vincristine—kidney cancer	0.00554	0.0103	CbGbCtD
Estradiol—CYP2C8—Pazopanib—kidney cancer	0.00524	0.00974	CbGbCtD
Estradiol—ALB—Erlotinib—kidney cancer	0.00484	0.009	CbGbCtD
Estradiol—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.00474	0.00883	CbGbCtD
Estradiol—CYP3A7—Paclitaxel—kidney cancer	0.00474	0.00883	CbGbCtD
Estradiol—ABCG2—Sunitinib—kidney cancer	0.00462	0.0086	CbGbCtD
Estradiol—CYP3A7—Sorafenib—kidney cancer	0.00421	0.00784	CbGbCtD
Estradiol—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.00421	0.00784	CbGbCtD
Estradiol—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.00409	0.00761	CbGbCtD
Estradiol—CYP3A7—Vincristine—kidney cancer	0.00409	0.00761	CbGbCtD
Estradiol—CYP1A2—Pazopanib—kidney cancer	0.00405	0.00754	CbGbCtD
Estradiol—CYP3A4—Temsirolimus—kidney cancer	0.00404	0.00752	CbGbCtD
Estradiol—CYP3A5—Erlotinib—kidney cancer	0.00389	0.00723	CbGbCtD
Estradiol—CYP2C9—Capecitabine—kidney cancer	0.00381	0.00709	CbGbCtD
Estradiol—CYP2C8—Erlotinib—kidney cancer	0.00374	0.00695	CbGbCtD
Estradiol—CYP3A5—Paclitaxel—kidney cancer	0.00356	0.00662	CbGbCtD
Estradiol—ABCB1—Pazopanib—kidney cancer	0.00354	0.0066	CbGbCtD
Estradiol—ABCG2—Doxorubicin—kidney cancer	0.00346	0.00644	CbGbCtD
Estradiol—CYP2C8—Paclitaxel—kidney cancer	0.00342	0.00637	CbGbCtD
Estradiol—CYP3A7—Sunitinib—kidney cancer	0.00341	0.00635	CbGbCtD
Estradiol—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.00341	0.00635	CbGbCtD
Estradiol—ABCB1—Dactinomycin—kidney cancer	0.00324	0.00603	CbGbCtD
Estradiol—CYP3A5—Sorafenib—kidney cancer	0.00316	0.00588	CbGbCtD
Estradiol—CYP3A5—Vincristine—kidney cancer	0.00307	0.00571	CbGbCtD
Estradiol—CYP2C8—Sorafenib—kidney cancer	0.00304	0.00565	CbGbCtD
Estradiol—SLC22A2—nephron—kidney cancer	0.00291	0.0549	CbGeAlD
Estradiol—CYP1A2—Erlotinib—kidney cancer	0.00289	0.00538	CbGbCtD
Estradiol—ABCB1—Gemcitabine—kidney cancer	0.00256	0.00477	CbGbCtD
Estradiol—CYP3A5—Sunitinib—kidney cancer	0.00256	0.00476	CbGbCtD
Estradiol—CYP2C19—Sorafenib—kidney cancer	0.00255	0.00474	CbGbCtD
Estradiol—ABCB1—Erlotinib—kidney cancer	0.00253	0.00471	CbGbCtD
Estradiol—CYP2C9—Paclitaxel—kidney cancer	0.00239	0.00444	CbGbCtD
Estradiol—ESRRB—cortex of kidney—kidney cancer	0.00236	0.0445	CbGeAlD
Estradiol—CYP1A2—Sorafenib—kidney cancer	0.00235	0.00438	CbGbCtD
Estradiol—UGT1A1—urine—kidney cancer	0.00234	0.0442	CbGeAlD
Estradiol—ABCB1—Paclitaxel—kidney cancer	0.00232	0.00431	CbGbCtD
Estradiol—ESRRB—gonad—kidney cancer	0.00225	0.0424	CbGeAlD
Estradiol—CYP3A4—Pazopanib—kidney cancer	0.00212	0.00395	CbGbCtD
Estradiol—CYP2C9—Sorafenib—kidney cancer	0.00212	0.00394	CbGbCtD
Estradiol—ABCB1—Sorafenib—kidney cancer	0.00206	0.00383	CbGbCtD
Estradiol—ABCB1—Vinblastine—kidney cancer	0.00203	0.00378	CbGbCtD
Estradiol—ABCB1—Vincristine—kidney cancer	0.002	0.00372	CbGbCtD
Estradiol—SLC22A8—nephron—kidney cancer	0.00189	0.0356	CbGeAlD
Estradiol—ABCB1—Sunitinib—kidney cancer	0.00167	0.0031	CbGbCtD
Estradiol—CYP3A4—Erlotinib—kidney cancer	0.00152	0.00282	CbGbCtD
Estradiol—SLC22A8—urine—kidney cancer	0.00152	0.0286	CbGeAlD
Estradiol—CYP3A4—Paclitaxel—kidney cancer	0.00139	0.00258	CbGbCtD
Estradiol—CYP2C19—urine—kidney cancer	0.00127	0.024	CbGeAlD
Estradiol—ABCB1—Doxorubicin—kidney cancer	0.00125	0.00232	CbGbCtD
Estradiol—CYP3A4—Sorafenib—kidney cancer	0.00123	0.00229	CbGbCtD
Estradiol—CYP3A4—Vinblastine—kidney cancer	0.00122	0.00226	CbGbCtD
Estradiol—CYP3A4—Vincristine—kidney cancer	0.0012	0.00223	CbGbCtD
Estradiol—CYP1A2—urine—kidney cancer	0.00104	0.0196	CbGeAlD
Estradiol—CYP3A4—Sunitinib—kidney cancer	0.000998	0.00186	CbGbCtD
Estradiol—CYP2C9—urine—kidney cancer	0.000985	0.0186	CbGeAlD
Estradiol—ESRRA—nephron tubule—kidney cancer	0.000881	0.0166	CbGeAlD
Estradiol—ESRRA—renal system—kidney cancer	0.000801	0.0151	CbGeAlD
Estradiol—ESRRA—kidney—kidney cancer	0.000774	0.0146	CbGeAlD
Estradiol—ESRRA—cortex of kidney—kidney cancer	0.000754	0.0142	CbGeAlD
Estradiol—CYP3A4—urine—kidney cancer	0.000751	0.0142	CbGeAlD
Estradiol—CYP3A4—Doxorubicin—kidney cancer	0.000748	0.00139	CbGbCtD
Estradiol—SLC22A11—nephron tubule—kidney cancer	0.000723	0.0136	CbGeAlD
Estradiol—ESRRA—cardiac atrium—kidney cancer	0.000717	0.0135	CbGeAlD
Estradiol—SLCO1C1—renal system—kidney cancer	0.000677	0.0128	CbGeAlD
Estradiol—SLC22A11—renal system—kidney cancer	0.000657	0.0124	CbGeAlD
Estradiol—SLCO1C1—kidney—kidney cancer	0.000654	0.0123	CbGeAlD
Estradiol—CYP3A7-CYP3A51P—nephron tubule—kidney cancer	0.000651	0.0123	CbGeAlD
Estradiol—SLC22A11—kidney—kidney cancer	0.000635	0.012	CbGeAlD
Estradiol—SLC22A2—nephron tubule—kidney cancer	0.000628	0.0118	CbGeAlD
Estradiol—SLC22A11—cortex of kidney—kidney cancer	0.000619	0.0117	CbGeAlD
Estradiol—SLCO4A1—nephron tubule—kidney cancer	0.000596	0.0112	CbGeAlD
Estradiol—UGT1A1—renal system—kidney cancer	0.000573	0.0108	CbGeAlD
Estradiol—SLC22A2—renal system—kidney cancer	0.000571	0.0108	CbGeAlD
Estradiol—CYP3A7-CYP3A51P—cortex of kidney—kidney cancer	0.000557	0.0105	CbGeAlD
Estradiol—UGT1A1—kidney—kidney cancer	0.000554	0.0105	CbGeAlD
Estradiol—SLC22A2—kidney—kidney cancer	0.000552	0.0104	CbGeAlD
Estradiol—SLCO4A1—renal system—kidney cancer	0.000542	0.0102	CbGeAlD
Estradiol—SLC22A2—cortex of kidney—kidney cancer	0.000537	0.0101	CbGeAlD
Estradiol—SLCO4A1—kidney—kidney cancer	0.000524	0.00988	CbGeAlD
Estradiol—SLCO4A1—cortex of kidney—kidney cancer	0.00051	0.00963	CbGeAlD
Estradiol—AOX1—nephron tubule—kidney cancer	0.000509	0.0096	CbGeAlD
Estradiol—SLCO4A1—cardiac atrium—kidney cancer	0.000486	0.00916	CbGeAlD
Estradiol—ESR2—renal system—kidney cancer	0.000481	0.00907	CbGeAlD
Estradiol—SLCO1B1—renal system—kidney cancer	0.000477	0.009	CbGeAlD
Estradiol—ESR2—kidney—kidney cancer	0.000465	0.00877	CbGeAlD
Estradiol—AOX1—renal system—kidney cancer	0.000463	0.00873	CbGeAlD
Estradiol—SLCO1B1—kidney—kidney cancer	0.000461	0.0087	CbGeAlD
Estradiol—ABCC10—renal system—kidney cancer	0.00045	0.00849	CbGeAlD
Estradiol—AOX1—kidney—kidney cancer	0.000447	0.00844	CbGeAlD
Estradiol—AOX1—cortex of kidney—kidney cancer	0.000436	0.00822	CbGeAlD
Estradiol—ABCC10—kidney—kidney cancer	0.000435	0.00821	CbGeAlD
Estradiol—ESR2—gonad—kidney cancer	0.000431	0.00813	CbGeAlD
Estradiol—ABCC10—cortex of kidney—kidney cancer	0.000424	0.008	CbGeAlD
Estradiol—SLCO2B1—renal system—kidney cancer	0.000422	0.00796	CbGeAlD
Estradiol—SHBG—gonad—kidney cancer	0.000419	0.0079	CbGeAlD
Estradiol—AOX1—gonad—kidney cancer	0.000415	0.00783	CbGeAlD
Estradiol—AOX1—cardiac atrium—kidney cancer	0.000414	0.00782	CbGeAlD
Estradiol—SLCO2B1—kidney—kidney cancer	0.000408	0.00769	CbGeAlD
Estradiol—SLC22A8—nephron tubule—kidney cancer	0.000408	0.00769	CbGeAlD
Estradiol—ABCC10—gonad—kidney cancer	0.000404	0.00762	CbGeAlD
Estradiol—ABCC10—cardiac atrium—kidney cancer	0.000403	0.00761	CbGeAlD
Estradiol—SLC22A1—renal system—kidney cancer	0.000403	0.0076	CbGeAlD
Estradiol—SLC22A1—kidney—kidney cancer	0.00039	0.00735	CbGeAlD
Estradiol—CYP1B1—nephron tubule—kidney cancer	0.00039	0.00735	CbGeAlD
Estradiol—SLCO1A2—renal system—kidney cancer	0.000388	0.00732	CbGeAlD
Estradiol—SLC22A3—renal system—kidney cancer	0.000385	0.00727	CbGeAlD
Estradiol—SLCO1A2—kidney—kidney cancer	0.000375	0.00708	CbGeAlD
Estradiol—SLC22A3—kidney—kidney cancer	0.000373	0.00703	CbGeAlD
Estradiol—SLC22A8—renal system—kidney cancer	0.000371	0.00699	CbGeAlD
Estradiol—SLC22A8—kidney—kidney cancer	0.000358	0.00676	CbGeAlD
Estradiol—CYP1B1—renal system—kidney cancer	0.000354	0.00668	CbGeAlD
Estradiol—SLC22A8—cortex of kidney—kidney cancer	0.000349	0.00658	CbGeAlD
Estradiol—SLC22A3—gonad—kidney cancer	0.000346	0.00652	CbGeAlD
Estradiol—CYP1B1—kidney—kidney cancer	0.000342	0.00646	CbGeAlD
Estradiol—AR—renal system—kidney cancer	0.000335	0.00633	CbGeAlD
Estradiol—CYP1B1—cortex of kidney—kidney cancer	0.000333	0.00629	CbGeAlD
Estradiol—ESR1—renal system—kidney cancer	0.000329	0.00621	CbGeAlD
Estradiol—AR—kidney—kidney cancer	0.000324	0.00612	CbGeAlD
Estradiol—ESR1—kidney—kidney cancer	0.000318	0.006	CbGeAlD
Estradiol—CYP1B1—gonad—kidney cancer	0.000318	0.00599	CbGeAlD
Estradiol—AR—cortex of kidney—kidney cancer	0.000316	0.00596	CbGeAlD
Estradiol—AR—gonad—kidney cancer	0.000301	0.00567	CbGeAlD
Estradiol—AR—cardiac atrium—kidney cancer	0.0003	0.00567	CbGeAlD
Estradiol—ESR1—gonad—kidney cancer	0.000295	0.00557	CbGeAlD
Estradiol—ABCG2—nephron tubule—kidney cancer	0.00029	0.00547	CbGeAlD
Estradiol—CYP2C8—renal system—kidney cancer	0.000271	0.00512	CbGeAlD
Estradiol—CYP3A5—nephron tubule—kidney cancer	0.000269	0.00508	CbGeAlD
Estradiol—CYP2C8—kidney—kidney cancer	0.000262	0.00495	CbGeAlD
Estradiol—CYP1A2—renal system—kidney cancer	0.000254	0.00479	CbGeAlD
Estradiol—CYP1A1—renal system—kidney cancer	0.00025	0.00472	CbGeAlD
Estradiol—CYP3A5—renal system—kidney cancer	0.000245	0.00462	CbGeAlD
Estradiol—CYP1A1—kidney—kidney cancer	0.000242	0.00457	CbGeAlD
Estradiol—CYP3A5—kidney—kidney cancer	0.000237	0.00446	CbGeAlD
Estradiol—CYP3A5—cortex of kidney—kidney cancer	0.000231	0.00435	CbGeAlD
Estradiol—CYP1A1—cardiac atrium—kidney cancer	0.000224	0.00423	CbGeAlD
Estradiol—CYP3A4—renal system—kidney cancer	0.000184	0.00347	CbGeAlD
Estradiol—CYP3A4—kidney—kidney cancer	0.000178	0.00335	CbGeAlD
Estradiol—ABCB1—nephron tubule—kidney cancer	0.000143	0.0027	CbGeAlD
Estradiol—ABCB1—renal system—kidney cancer	0.00013	0.00245	CbGeAlD
Estradiol—ABCB1—kidney—kidney cancer	0.000126	0.00237	CbGeAlD
Estradiol—ABCB1—cortex of kidney—kidney cancer	0.000122	0.00231	CbGeAlD
Estradiol—Estriol—ABCB1—kidney cancer	0.000122	0.194	CrCbGaD
Estradiol—ABCB1—gonad—kidney cancer	0.000117	0.0022	CbGeAlD
Estradiol—Estramustine—ABCB1—kidney cancer	0.000113	0.18	CrCbGaD
Estradiol—Estrone—CYP1A1—kidney cancer	0.000109	0.174	CrCbGaD
Estradiol—Ethinyl Estradiol—ABCB1—kidney cancer	6.67e-05	0.106	CrCbGaD
Estradiol—Testosterone—CYP1A1—kidney cancer	6.64e-05	0.106	CrCbGaD
Estradiol—Conjugated Estrogens—ABCB1—kidney cancer	5.82e-05	0.0925	CrCbGaD
Estradiol—Estrone—ABCB1—kidney cancer	5.81e-05	0.0923	CrCbGaD
Estradiol—Discomfort—Paclitaxel—kidney cancer	3.72e-05	0.000242	CcSEcCtD
Estradiol—Fatigue—Gemcitabine—kidney cancer	3.72e-05	0.000241	CcSEcCtD
Estradiol—Gastrointestinal pain—Vincristine—kidney cancer	3.72e-05	0.000241	CcSEcCtD
Estradiol—Dizziness—Sorafenib—kidney cancer	3.7e-05	0.00024	CcSEcCtD
Estradiol—Constipation—Gemcitabine—kidney cancer	3.69e-05	0.000239	CcSEcCtD
Estradiol—Pain—Gemcitabine—kidney cancer	3.69e-05	0.000239	CcSEcCtD
Estradiol—Nausea—Erlotinib—kidney cancer	3.69e-05	0.000239	CcSEcCtD
Estradiol—Alopecia—Capecitabine—kidney cancer	3.69e-05	0.000239	CcSEcCtD
Estradiol—Dry mouth—Paclitaxel—kidney cancer	3.69e-05	0.000239	CcSEcCtD
Estradiol—Mood swings—Doxorubicin—kidney cancer	3.68e-05	0.000239	CcSEcCtD
Estradiol—Diarrhoea—Sunitinib—kidney cancer	3.68e-05	0.000239	CcSEcCtD
Estradiol—Mental disorder—Capecitabine—kidney cancer	3.66e-05	0.000237	CcSEcCtD
Estradiol—Asthenia—Dactinomycin—kidney cancer	3.65e-05	0.000237	CcSEcCtD
Estradiol—Confusional state—Paclitaxel—kidney cancer	3.64e-05	0.000236	CcSEcCtD
Estradiol—Malnutrition—Capecitabine—kidney cancer	3.63e-05	0.000236	CcSEcCtD
Estradiol—Erythema—Capecitabine—kidney cancer	3.63e-05	0.000236	CcSEcCtD
Estradiol—Oedema—Paclitaxel—kidney cancer	3.61e-05	0.000234	CcSEcCtD
Estradiol—Anaphylactic shock—Paclitaxel—kidney cancer	3.61e-05	0.000234	CcSEcCtD
Estradiol—Abdominal pain—Vincristine—kidney cancer	3.6e-05	0.000233	CcSEcCtD
Estradiol—Body temperature increased—Vincristine—kidney cancer	3.6e-05	0.000233	CcSEcCtD
Estradiol—Liver function test abnormal—Doxorubicin—kidney cancer	3.59e-05	0.000233	CcSEcCtD
Estradiol—Infection—Paclitaxel—kidney cancer	3.59e-05	0.000233	CcSEcCtD
Estradiol—Flatulence—Capecitabine—kidney cancer	3.58e-05	0.000232	CcSEcCtD
Estradiol—Dry skin—Doxorubicin—kidney cancer	3.56e-05	0.000231	CcSEcCtD
Estradiol—Dysgeusia—Capecitabine—kidney cancer	3.56e-05	0.000231	CcSEcCtD
Estradiol—Dizziness—Sunitinib—kidney cancer	3.56e-05	0.000231	CcSEcCtD
Estradiol—Feeling abnormal—Gemcitabine—kidney cancer	3.56e-05	0.000231	CcSEcCtD
Estradiol—Shock—Paclitaxel—kidney cancer	3.55e-05	0.000231	CcSEcCtD
Estradiol—Vomiting—Sorafenib—kidney cancer	3.55e-05	0.000231	CcSEcCtD
Estradiol—Abdominal pain upper—Doxorubicin—kidney cancer	3.55e-05	0.00023	CcSEcCtD
Estradiol—Nervous system disorder—Paclitaxel—kidney cancer	3.54e-05	0.00023	CcSEcCtD
Estradiol—Testosterone—ABCB1—kidney cancer	3.53e-05	0.0561	CrCbGaD
Estradiol—Tachycardia—Paclitaxel—kidney cancer	3.53e-05	0.000229	CcSEcCtD
Estradiol—Rash—Sorafenib—kidney cancer	3.52e-05	0.000229	CcSEcCtD
Estradiol—Dermatitis—Sorafenib—kidney cancer	3.52e-05	0.000228	CcSEcCtD
Estradiol—Back pain—Capecitabine—kidney cancer	3.51e-05	0.000228	CcSEcCtD
Estradiol—Breast disorder—Doxorubicin—kidney cancer	3.51e-05	0.000228	CcSEcCtD
Estradiol—Skin disorder—Paclitaxel—kidney cancer	3.51e-05	0.000228	CcSEcCtD
Estradiol—Headache—Sorafenib—kidney cancer	3.5e-05	0.000227	CcSEcCtD
Estradiol—Muscle spasms—Capecitabine—kidney cancer	3.49e-05	0.000227	CcSEcCtD
Estradiol—Hyperhidrosis—Paclitaxel—kidney cancer	3.49e-05	0.000227	CcSEcCtD
Estradiol—Diarrhoea—Dactinomycin—kidney cancer	3.48e-05	0.000226	CcSEcCtD
Estradiol—Nasopharyngitis—Doxorubicin—kidney cancer	3.48e-05	0.000226	CcSEcCtD
Estradiol—Gastritis—Doxorubicin—kidney cancer	3.44e-05	0.000223	CcSEcCtD
Estradiol—Alanine aminotransferase increased—Doxorubicin—kidney cancer	3.43e-05	0.000222	CcSEcCtD
Estradiol—Vomiting—Sunitinib—kidney cancer	3.42e-05	0.000222	CcSEcCtD
Estradiol—Body temperature increased—Gemcitabine—kidney cancer	3.41e-05	0.000221	CcSEcCtD
Estradiol—Tremor—Capecitabine—kidney cancer	3.4e-05	0.000221	CcSEcCtD
Estradiol—Rash—Sunitinib—kidney cancer	3.39e-05	0.00022	CcSEcCtD
Estradiol—Dermatitis—Sunitinib—kidney cancer	3.39e-05	0.00022	CcSEcCtD
Estradiol—Abdominal distension—Doxorubicin—kidney cancer	3.38e-05	0.000219	CcSEcCtD
Estradiol—Ill-defined disorder—Capecitabine—kidney cancer	3.37e-05	0.000219	CcSEcCtD
Estradiol—Headache—Sunitinib—kidney cancer	3.37e-05	0.000219	CcSEcCtD
Estradiol—Dysphagia—Doxorubicin—kidney cancer	3.36e-05	0.000218	CcSEcCtD
Estradiol—Influenza—Doxorubicin—kidney cancer	3.36e-05	0.000218	CcSEcCtD
Estradiol—Asthma—Doxorubicin—kidney cancer	3.36e-05	0.000218	CcSEcCtD
Estradiol—Hypersensitivity—Vincristine—kidney cancer	3.35e-05	0.000217	CcSEcCtD
Estradiol—Nausea—Sorafenib—kidney cancer	3.32e-05	0.000215	CcSEcCtD
Estradiol—Pancreatitis—Doxorubicin—kidney cancer	3.29e-05	0.000214	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Paclitaxel—kidney cancer	3.29e-05	0.000214	CcSEcCtD
Estradiol—Malaise—Capecitabine—kidney cancer	3.28e-05	0.000213	CcSEcCtD
Estradiol—Insomnia—Paclitaxel—kidney cancer	3.27e-05	0.000212	CcSEcCtD
Estradiol—Vertigo—Capecitabine—kidney cancer	3.26e-05	0.000212	CcSEcCtD
Estradiol—Asthenia—Vincristine—kidney cancer	3.26e-05	0.000212	CcSEcCtD
Estradiol—Syncope—Capecitabine—kidney cancer	3.26e-05	0.000211	CcSEcCtD
Estradiol—Paraesthesia—Paclitaxel—kidney cancer	3.24e-05	0.00021	CcSEcCtD
Estradiol—Vomiting—Dactinomycin—kidney cancer	3.24e-05	0.00021	CcSEcCtD
Estradiol—Bronchitis—Doxorubicin—kidney cancer	3.23e-05	0.00021	CcSEcCtD
Estradiol—Dyspnoea—Paclitaxel—kidney cancer	3.22e-05	0.000209	CcSEcCtD
Estradiol—Somnolence—Paclitaxel—kidney cancer	3.21e-05	0.000208	CcSEcCtD
Estradiol—Palpitations—Capecitabine—kidney cancer	3.21e-05	0.000208	CcSEcCtD
Estradiol—Rash—Dactinomycin—kidney cancer	3.21e-05	0.000208	CcSEcCtD
Estradiol—Nausea—Sunitinib—kidney cancer	3.19e-05	0.000207	CcSEcCtD
Estradiol—Loss of consciousness—Capecitabine—kidney cancer	3.19e-05	0.000207	CcSEcCtD
Estradiol—Dyspepsia—Paclitaxel—kidney cancer	3.18e-05	0.000206	CcSEcCtD
Estradiol—Cough—Capecitabine—kidney cancer	3.17e-05	0.000206	CcSEcCtD
Estradiol—Decreased appetite—Paclitaxel—kidney cancer	3.14e-05	0.000204	CcSEcCtD
Estradiol—Hypertension—Capecitabine—kidney cancer	3.14e-05	0.000203	CcSEcCtD
Estradiol—Upper respiratory tract infection—Doxorubicin—kidney cancer	3.12e-05	0.000203	CcSEcCtD
Estradiol—Gastrointestinal disorder—Paclitaxel—kidney cancer	3.12e-05	0.000202	CcSEcCtD
Estradiol—Fatigue—Paclitaxel—kidney cancer	3.11e-05	0.000202	CcSEcCtD
Estradiol—Diarrhoea—Vincristine—kidney cancer	3.11e-05	0.000202	CcSEcCtD
Estradiol—Pollakiuria—Doxorubicin—kidney cancer	3.1e-05	0.000201	CcSEcCtD
Estradiol—Asthenia—Gemcitabine—kidney cancer	3.1e-05	0.000201	CcSEcCtD
Estradiol—Arthralgia—Capecitabine—kidney cancer	3.09e-05	0.000201	CcSEcCtD
Estradiol—Chest pain—Capecitabine—kidney cancer	3.09e-05	0.000201	CcSEcCtD
Estradiol—Myalgia—Capecitabine—kidney cancer	3.09e-05	0.000201	CcSEcCtD
Estradiol—Pain—Paclitaxel—kidney cancer	3.09e-05	0.0002	CcSEcCtD
Estradiol—Constipation—Paclitaxel—kidney cancer	3.09e-05	0.0002	CcSEcCtD
Estradiol—Anxiety—Capecitabine—kidney cancer	3.08e-05	0.0002	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	3.07e-05	0.000199	CcSEcCtD
Estradiol—Photosensitivity reaction—Doxorubicin—kidney cancer	3.07e-05	0.000199	CcSEcCtD
Estradiol—Weight increased—Doxorubicin—kidney cancer	3.06e-05	0.000198	CcSEcCtD
Estradiol—Discomfort—Capecitabine—kidney cancer	3.06e-05	0.000198	CcSEcCtD
Estradiol—Pruritus—Gemcitabine—kidney cancer	3.05e-05	0.000198	CcSEcCtD
Estradiol—Weight decreased—Doxorubicin—kidney cancer	3.04e-05	0.000197	CcSEcCtD
Estradiol—Hyperglycaemia—Doxorubicin—kidney cancer	3.03e-05	0.000197	CcSEcCtD
Estradiol—Dry mouth—Capecitabine—kidney cancer	3.02e-05	0.000196	CcSEcCtD
Estradiol—Nausea—Dactinomycin—kidney cancer	3.02e-05	0.000196	CcSEcCtD
Estradiol—Pneumonia—Doxorubicin—kidney cancer	3.01e-05	0.000196	CcSEcCtD
Estradiol—Dizziness—Vincristine—kidney cancer	3.01e-05	0.000195	CcSEcCtD
Estradiol—Infestation—Doxorubicin—kidney cancer	3e-05	0.000194	CcSEcCtD
Estradiol—Infestation NOS—Doxorubicin—kidney cancer	3e-05	0.000194	CcSEcCtD
Estradiol—Confusional state—Capecitabine—kidney cancer	2.99e-05	0.000194	CcSEcCtD
Estradiol—Feeling abnormal—Paclitaxel—kidney cancer	2.98e-05	0.000193	CcSEcCtD
Estradiol—Oedema—Capecitabine—kidney cancer	2.96e-05	0.000192	CcSEcCtD
Estradiol—Gastrointestinal pain—Paclitaxel—kidney cancer	2.95e-05	0.000192	CcSEcCtD
Estradiol—Diarrhoea—Gemcitabine—kidney cancer	2.95e-05	0.000192	CcSEcCtD
Estradiol—Infection—Capecitabine—kidney cancer	2.95e-05	0.000191	CcSEcCtD
Estradiol—Neuropathy peripheral—Doxorubicin—kidney cancer	2.94e-05	0.000191	CcSEcCtD
Estradiol—Jaundice—Doxorubicin—kidney cancer	2.92e-05	0.000189	CcSEcCtD
Estradiol—Shock—Capecitabine—kidney cancer	2.92e-05	0.000189	CcSEcCtD
Estradiol—Conjunctivitis—Doxorubicin—kidney cancer	2.91e-05	0.000189	CcSEcCtD
Estradiol—Urinary tract infection—Doxorubicin—kidney cancer	2.91e-05	0.000189	CcSEcCtD
Estradiol—Nervous system disorder—Capecitabine—kidney cancer	2.91e-05	0.000189	CcSEcCtD
Estradiol—Tachycardia—Capecitabine—kidney cancer	2.89e-05	0.000188	CcSEcCtD
Estradiol—Vomiting—Vincristine—kidney cancer	2.89e-05	0.000188	CcSEcCtD
Estradiol—Skin disorder—Capecitabine—kidney cancer	2.88e-05	0.000187	CcSEcCtD
Estradiol—Urticaria—Paclitaxel—kidney cancer	2.87e-05	0.000186	CcSEcCtD
Estradiol—Rash—Vincristine—kidney cancer	2.87e-05	0.000186	CcSEcCtD
Estradiol—Hyperhidrosis—Capecitabine—kidney cancer	2.87e-05	0.000186	CcSEcCtD
Estradiol—Dermatitis—Vincristine—kidney cancer	2.87e-05	0.000186	CcSEcCtD
Estradiol—Haematuria—Doxorubicin—kidney cancer	2.86e-05	0.000185	CcSEcCtD
Estradiol—Abdominal pain—Paclitaxel—kidney cancer	2.86e-05	0.000185	CcSEcCtD
Estradiol—Body temperature increased—Paclitaxel—kidney cancer	2.86e-05	0.000185	CcSEcCtD
Estradiol—Headache—Vincristine—kidney cancer	2.85e-05	0.000185	CcSEcCtD
Estradiol—Hepatobiliary disease—Doxorubicin—kidney cancer	2.83e-05	0.000184	CcSEcCtD
Estradiol—Epistaxis—Doxorubicin—kidney cancer	2.83e-05	0.000183	CcSEcCtD
Estradiol—Sinusitis—Doxorubicin—kidney cancer	2.81e-05	0.000182	CcSEcCtD
Estradiol—Vomiting—Gemcitabine—kidney cancer	2.74e-05	0.000178	CcSEcCtD
Estradiol—Rash—Gemcitabine—kidney cancer	2.72e-05	0.000176	CcSEcCtD
Estradiol—Dermatitis—Gemcitabine—kidney cancer	2.72e-05	0.000176	CcSEcCtD
Estradiol—Haemoglobin—Doxorubicin—kidney cancer	2.7e-05	0.000175	CcSEcCtD
Estradiol—Headache—Gemcitabine—kidney cancer	2.7e-05	0.000175	CcSEcCtD
Estradiol—Nausea—Vincristine—kidney cancer	2.7e-05	0.000175	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Capecitabine—kidney cancer	2.7e-05	0.000175	CcSEcCtD
Estradiol—Rhinitis—Doxorubicin—kidney cancer	2.7e-05	0.000175	CcSEcCtD
Estradiol—Haemorrhage—Doxorubicin—kidney cancer	2.69e-05	0.000175	CcSEcCtD
Estradiol—Hepatitis—Doxorubicin—kidney cancer	2.69e-05	0.000175	CcSEcCtD
Estradiol—Insomnia—Capecitabine—kidney cancer	2.68e-05	0.000174	CcSEcCtD
Estradiol—Hypoaesthesia—Doxorubicin—kidney cancer	2.68e-05	0.000174	CcSEcCtD
Estradiol—Pharyngitis—Doxorubicin—kidney cancer	2.67e-05	0.000173	CcSEcCtD
Estradiol—Paraesthesia—Capecitabine—kidney cancer	2.66e-05	0.000173	CcSEcCtD
Estradiol—Hypersensitivity—Paclitaxel—kidney cancer	2.66e-05	0.000173	CcSEcCtD
Estradiol—Urinary tract disorder—Doxorubicin—kidney cancer	2.66e-05	0.000172	CcSEcCtD
Estradiol—Oedema peripheral—Doxorubicin—kidney cancer	2.65e-05	0.000172	CcSEcCtD
Estradiol—Connective tissue disorder—Doxorubicin—kidney cancer	2.64e-05	0.000171	CcSEcCtD
Estradiol—Dyspnoea—Capecitabine—kidney cancer	2.64e-05	0.000171	CcSEcCtD
Estradiol—Urethral disorder—Doxorubicin—kidney cancer	2.64e-05	0.000171	CcSEcCtD
Estradiol—Dyspepsia—Capecitabine—kidney cancer	2.61e-05	0.000169	CcSEcCtD
Estradiol—Visual impairment—Doxorubicin—kidney cancer	2.59e-05	0.000168	CcSEcCtD
Estradiol—Asthenia—Paclitaxel—kidney cancer	2.59e-05	0.000168	CcSEcCtD
Estradiol—Decreased appetite—Capecitabine—kidney cancer	2.58e-05	0.000167	CcSEcCtD
Estradiol—Nausea—Gemcitabine—kidney cancer	2.56e-05	0.000166	CcSEcCtD
Estradiol—Gastrointestinal disorder—Capecitabine—kidney cancer	2.56e-05	0.000166	CcSEcCtD
Estradiol—Fatigue—Capecitabine—kidney cancer	2.56e-05	0.000166	CcSEcCtD
Estradiol—Pruritus—Paclitaxel—kidney cancer	2.56e-05	0.000166	CcSEcCtD
Estradiol—Erythema multiforme—Doxorubicin—kidney cancer	2.54e-05	0.000165	CcSEcCtD
Estradiol—Pain—Capecitabine—kidney cancer	2.54e-05	0.000164	CcSEcCtD
Estradiol—Constipation—Capecitabine—kidney cancer	2.54e-05	0.000164	CcSEcCtD
Estradiol—Eye disorder—Doxorubicin—kidney cancer	2.51e-05	0.000163	CcSEcCtD
Estradiol—Tinnitus—Doxorubicin—kidney cancer	2.51e-05	0.000163	CcSEcCtD
Estradiol—Flushing—Doxorubicin—kidney cancer	2.5e-05	0.000162	CcSEcCtD
Estradiol—Cardiac disorder—Doxorubicin—kidney cancer	2.5e-05	0.000162	CcSEcCtD
Estradiol—Diarrhoea—Paclitaxel—kidney cancer	2.47e-05	0.00016	CcSEcCtD
Estradiol—Feeling abnormal—Capecitabine—kidney cancer	2.44e-05	0.000158	CcSEcCtD
Estradiol—Angiopathy—Doxorubicin—kidney cancer	2.44e-05	0.000158	CcSEcCtD
Estradiol—Immune system disorder—Doxorubicin—kidney cancer	2.43e-05	0.000158	CcSEcCtD
Estradiol—Gastrointestinal pain—Capecitabine—kidney cancer	2.42e-05	0.000157	CcSEcCtD
Estradiol—Mediastinal disorder—Doxorubicin—kidney cancer	2.42e-05	0.000157	CcSEcCtD
Estradiol—Chills—Doxorubicin—kidney cancer	2.41e-05	0.000157	CcSEcCtD
Estradiol—Dizziness—Paclitaxel—kidney cancer	2.39e-05	0.000155	CcSEcCtD
Estradiol—Alopecia—Doxorubicin—kidney cancer	2.38e-05	0.000154	CcSEcCtD
Estradiol—Mental disorder—Doxorubicin—kidney cancer	2.36e-05	0.000153	CcSEcCtD
Estradiol—Urticaria—Capecitabine—kidney cancer	2.36e-05	0.000153	CcSEcCtD
Estradiol—Abdominal pain—Capecitabine—kidney cancer	2.34e-05	0.000152	CcSEcCtD
Estradiol—Body temperature increased—Capecitabine—kidney cancer	2.34e-05	0.000152	CcSEcCtD
Estradiol—Erythema—Doxorubicin—kidney cancer	2.34e-05	0.000152	CcSEcCtD
Estradiol—Malnutrition—Doxorubicin—kidney cancer	2.34e-05	0.000152	CcSEcCtD
Estradiol—Flatulence—Doxorubicin—kidney cancer	2.31e-05	0.00015	CcSEcCtD
Estradiol—Tension—Doxorubicin—kidney cancer	2.3e-05	0.000149	CcSEcCtD
Estradiol—Vomiting—Paclitaxel—kidney cancer	2.3e-05	0.000149	CcSEcCtD
Estradiol—Dysgeusia—Doxorubicin—kidney cancer	2.29e-05	0.000149	CcSEcCtD
Estradiol—Rash—Paclitaxel—kidney cancer	2.28e-05	0.000148	CcSEcCtD
Estradiol—Dermatitis—Paclitaxel—kidney cancer	2.28e-05	0.000148	CcSEcCtD
Estradiol—Nervousness—Doxorubicin—kidney cancer	2.27e-05	0.000148	CcSEcCtD
Estradiol—Back pain—Doxorubicin—kidney cancer	2.26e-05	0.000147	CcSEcCtD
Estradiol—Headache—Paclitaxel—kidney cancer	2.26e-05	0.000147	CcSEcCtD
Estradiol—Muscle spasms—Doxorubicin—kidney cancer	2.25e-05	0.000146	CcSEcCtD
Estradiol—Hypersensitivity—Capecitabine—kidney cancer	2.18e-05	0.000142	CcSEcCtD
Estradiol—Ill-defined disorder—Doxorubicin—kidney cancer	2.17e-05	0.000141	CcSEcCtD
Estradiol—Agitation—Doxorubicin—kidney cancer	2.15e-05	0.00014	CcSEcCtD
Estradiol—Nausea—Paclitaxel—kidney cancer	2.15e-05	0.000139	CcSEcCtD
Estradiol—Asthenia—Capecitabine—kidney cancer	2.13e-05	0.000138	CcSEcCtD
Estradiol—Malaise—Doxorubicin—kidney cancer	2.11e-05	0.000137	CcSEcCtD
Estradiol—Vertigo—Doxorubicin—kidney cancer	2.1e-05	0.000136	CcSEcCtD
Estradiol—Syncope—Doxorubicin—kidney cancer	2.1e-05	0.000136	CcSEcCtD
Estradiol—Pruritus—Capecitabine—kidney cancer	2.1e-05	0.000136	CcSEcCtD
Estradiol—Palpitations—Doxorubicin—kidney cancer	2.07e-05	0.000134	CcSEcCtD
Estradiol—Loss of consciousness—Doxorubicin—kidney cancer	2.06e-05	0.000134	CcSEcCtD
Estradiol—Cough—Doxorubicin—kidney cancer	2.04e-05	0.000133	CcSEcCtD
Estradiol—Diarrhoea—Capecitabine—kidney cancer	2.03e-05	0.000132	CcSEcCtD
Estradiol—Hypertension—Doxorubicin—kidney cancer	2.02e-05	0.000131	CcSEcCtD
Estradiol—Myalgia—Doxorubicin—kidney cancer	1.99e-05	0.000129	CcSEcCtD
Estradiol—Arthralgia—Doxorubicin—kidney cancer	1.99e-05	0.000129	CcSEcCtD
Estradiol—Chest pain—Doxorubicin—kidney cancer	1.99e-05	0.000129	CcSEcCtD
Estradiol—Anxiety—Doxorubicin—kidney cancer	1.99e-05	0.000129	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	1.98e-05	0.000128	CcSEcCtD
Estradiol—Discomfort—Doxorubicin—kidney cancer	1.97e-05	0.000128	CcSEcCtD
Estradiol—Dizziness—Capecitabine—kidney cancer	1.96e-05	0.000127	CcSEcCtD
Estradiol—Dry mouth—Doxorubicin—kidney cancer	1.95e-05	0.000126	CcSEcCtD
Estradiol—Confusional state—Doxorubicin—kidney cancer	1.93e-05	0.000125	CcSEcCtD
Estradiol—Oedema—Doxorubicin—kidney cancer	1.91e-05	0.000124	CcSEcCtD
Estradiol—Anaphylactic shock—Doxorubicin—kidney cancer	1.91e-05	0.000124	CcSEcCtD
Estradiol—Infection—Doxorubicin—kidney cancer	1.9e-05	0.000123	CcSEcCtD
Estradiol—Vomiting—Capecitabine—kidney cancer	1.88e-05	0.000122	CcSEcCtD
Estradiol—Shock—Doxorubicin—kidney cancer	1.88e-05	0.000122	CcSEcCtD
Estradiol—Nervous system disorder—Doxorubicin—kidney cancer	1.87e-05	0.000122	CcSEcCtD
Estradiol—Rash—Capecitabine—kidney cancer	1.87e-05	0.000121	CcSEcCtD
Estradiol—Dermatitis—Capecitabine—kidney cancer	1.87e-05	0.000121	CcSEcCtD
Estradiol—Tachycardia—Doxorubicin—kidney cancer	1.87e-05	0.000121	CcSEcCtD
Estradiol—Headache—Capecitabine—kidney cancer	1.86e-05	0.00012	CcSEcCtD
Estradiol—Skin disorder—Doxorubicin—kidney cancer	1.86e-05	0.00012	CcSEcCtD
Estradiol—Hyperhidrosis—Doxorubicin—kidney cancer	1.85e-05	0.00012	CcSEcCtD
Estradiol—Nausea—Capecitabine—kidney cancer	1.76e-05	0.000114	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Doxorubicin—kidney cancer	1.74e-05	0.000113	CcSEcCtD
Estradiol—Insomnia—Doxorubicin—kidney cancer	1.73e-05	0.000112	CcSEcCtD
Estradiol—Paraesthesia—Doxorubicin—kidney cancer	1.72e-05	0.000111	CcSEcCtD
Estradiol—Dyspnoea—Doxorubicin—kidney cancer	1.7e-05	0.000111	CcSEcCtD
Estradiol—Somnolence—Doxorubicin—kidney cancer	1.7e-05	0.00011	CcSEcCtD
Estradiol—Dyspepsia—Doxorubicin—kidney cancer	1.68e-05	0.000109	CcSEcCtD
Estradiol—Decreased appetite—Doxorubicin—kidney cancer	1.66e-05	0.000108	CcSEcCtD
Estradiol—Gastrointestinal disorder—Doxorubicin—kidney cancer	1.65e-05	0.000107	CcSEcCtD
Estradiol—Fatigue—Doxorubicin—kidney cancer	1.65e-05	0.000107	CcSEcCtD
Estradiol—Constipation—Doxorubicin—kidney cancer	1.63e-05	0.000106	CcSEcCtD
Estradiol—Pain—Doxorubicin—kidney cancer	1.63e-05	0.000106	CcSEcCtD
Estradiol—Feeling abnormal—Doxorubicin—kidney cancer	1.57e-05	0.000102	CcSEcCtD
Estradiol—Gastrointestinal pain—Doxorubicin—kidney cancer	1.56e-05	0.000101	CcSEcCtD
Estradiol—Urticaria—Doxorubicin—kidney cancer	1.52e-05	9.85e-05	CcSEcCtD
Estradiol—Abdominal pain—Doxorubicin—kidney cancer	1.51e-05	9.8e-05	CcSEcCtD
Estradiol—Body temperature increased—Doxorubicin—kidney cancer	1.51e-05	9.8e-05	CcSEcCtD
Estradiol—Hypersensitivity—Doxorubicin—kidney cancer	1.41e-05	9.13e-05	CcSEcCtD
Estradiol—Asthenia—Doxorubicin—kidney cancer	1.37e-05	8.9e-05	CcSEcCtD
Estradiol—Pruritus—Doxorubicin—kidney cancer	1.35e-05	8.77e-05	CcSEcCtD
Estradiol—Diarrhoea—Doxorubicin—kidney cancer	1.31e-05	8.48e-05	CcSEcCtD
Estradiol—Dizziness—Doxorubicin—kidney cancer	1.26e-05	8.2e-05	CcSEcCtD
Estradiol—Vomiting—Doxorubicin—kidney cancer	1.22e-05	7.88e-05	CcSEcCtD
Estradiol—Rash—Doxorubicin—kidney cancer	1.2e-05	7.82e-05	CcSEcCtD
Estradiol—Dermatitis—Doxorubicin—kidney cancer	1.2e-05	7.81e-05	CcSEcCtD
Estradiol—Headache—Doxorubicin—kidney cancer	1.2e-05	7.77e-05	CcSEcCtD
Estradiol—Nausea—Doxorubicin—kidney cancer	1.14e-05	7.36e-05	CcSEcCtD
Estradiol—CYP1A2—Metabolism—CA9—kidney cancer	3.66e-06	5.33e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—CYP1A1—kidney cancer	3.66e-06	5.33e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—CYP1A1—kidney cancer	3.66e-06	5.32e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—CRABP1—kidney cancer	3.64e-06	5.3e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—SLC2A1—kidney cancer	3.64e-06	5.3e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—ALAD—kidney cancer	3.64e-06	5.29e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—ITPR2—kidney cancer	3.63e-06	5.28e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—BCHE—kidney cancer	3.61e-06	5.25e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—GSTM1—kidney cancer	3.59e-06	5.23e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—SCARB1—kidney cancer	3.59e-06	5.23e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.58e-06	5.21e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—SCARB1—kidney cancer	3.57e-06	5.2e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—SLC5A5—kidney cancer	3.56e-06	5.18e-05	CbGpPWpGaD
Estradiol—AOX1—Disease—PIK3CA—kidney cancer	3.56e-06	5.18e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PTGS1—kidney cancer	3.56e-06	5.17e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—ST3GAL2—kidney cancer	3.55e-06	5.16e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—PTGS1—kidney cancer	3.54e-06	5.14e-05	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—PTGS2—kidney cancer	3.53e-06	5.14e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—IGF2—kidney cancer	3.53e-06	5.13e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CDKN2B—kidney cancer	3.51e-06	5.11e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PSMD7—kidney cancer	3.49e-06	5.07e-05	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—POMC—kidney cancer	3.48e-06	5.06e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—PSMD7—kidney cancer	3.47e-06	5.05e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—ALDH1A1—kidney cancer	3.47e-06	5.04e-05	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—PTGS2—kidney cancer	3.47e-06	5.04e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—RAF1—kidney cancer	3.46e-06	5.03e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—SLC2A1—kidney cancer	3.44e-06	5.01e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.43e-06	4.98e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—IGF1R—kidney cancer	3.41e-06	4.96e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—CYP1A1—kidney cancer	3.41e-06	4.96e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—ACHE—kidney cancer	3.39e-06	4.93e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—GSTT1—kidney cancer	3.39e-06	4.93e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—ITPR2—kidney cancer	3.39e-06	4.93e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.34e-06	4.86e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.34e-06	4.85e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PGK1—kidney cancer	3.32e-06	4.84e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—SLC5A3—kidney cancer	3.32e-06	4.84e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—GSTT1—kidney cancer	3.31e-06	4.81e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—ACHE—kidney cancer	3.31e-06	4.81e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—BCHE—kidney cancer	3.31e-06	4.81e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—BCHE—kidney cancer	3.29e-06	4.78e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.28e-06	4.77e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—SLC5A5—kidney cancer	3.27e-06	4.75e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—LDHB—kidney cancer	3.26e-06	4.74e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—SLC5A5—kidney cancer	3.25e-06	4.72e-05	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—POMC—kidney cancer	3.25e-06	4.72e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—SCARB1—kidney cancer	3.21e-06	4.67e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PTGS1—kidney cancer	3.18e-06	4.62e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—SLC2A1—kidney cancer	3.16e-06	4.59e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—SLC2A1—kidney cancer	3.14e-06	4.56e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—SCARB1—kidney cancer	3.13e-06	4.55e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.12e-06	4.54e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—CRABP1—kidney cancer	3.11e-06	4.53e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PSMD7—kidney cancer	3.11e-06	4.53e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PTGS1—kidney cancer	3.1e-06	4.51e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—IL2—kidney cancer	3.1e-06	4.51e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—GSTT1—kidney cancer	3.09e-06	4.49e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—ACHE—kidney cancer	3.09e-06	4.49e-05	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—PTEN—kidney cancer	3.08e-06	4.48e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.06e-06	4.45e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.04e-06	4.43e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PSMD7—kidney cancer	3.04e-06	4.42e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—GSTP1—kidney cancer	3.04e-06	4.42e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—POMC—kidney cancer	3.03e-06	4.4e-05	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—PTEN—kidney cancer	3.02e-06	4.4e-05	CbGpPWpGaD
Estradiol—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	2.99e-06	4.35e-05	CbGpPWpGaD
Estradiol—AOX1—Metabolism—PIK3CA—kidney cancer	2.98e-06	4.34e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—POMC—kidney cancer	2.97e-06	4.33e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—BCHE—kidney cancer	2.95e-06	4.29e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—SCARB1—kidney cancer	2.93e-06	4.25e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—SLC5A5—kidney cancer	2.92e-06	4.24e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.91e-06	4.24e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—ITPR2—kidney cancer	2.9e-06	4.21e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PTGS1—kidney cancer	2.9e-06	4.21e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—BCHE—kidney cancer	2.88e-06	4.19e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—ABCB1—kidney cancer	2.88e-06	4.18e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—GSTP1—kidney cancer	2.87e-06	4.17e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—SLC5A5—kidney cancer	2.85e-06	4.14e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PSMD7—kidney cancer	2.84e-06	4.13e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—CA9—kidney cancer	2.83e-06	4.11e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—SLC2A1—kidney cancer	2.82e-06	4.1e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—HIF1A—kidney cancer	2.81e-06	4.08e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—TSC2—kidney cancer	2.8e-06	4.07e-05	CbGpPWpGaD
Estradiol—AR—Gene Expression—MAPK3—kidney cancer	2.79e-06	4.06e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—GSTM1—kidney cancer	2.79e-06	4.06e-05	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—PTGS2—kidney cancer	2.77e-06	4.04e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—POMC—kidney cancer	2.75e-06	4.01e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—SLC2A1—kidney cancer	2.75e-06	4e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.73e-06	3.97e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—POMC—kidney cancer	2.73e-06	3.97e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—POMC—kidney cancer	2.73e-06	3.96e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—ABCB1—kidney cancer	2.72e-06	3.95e-05	CbGpPWpGaD
Estradiol—AR—Gene Expression—MYC—kidney cancer	2.72e-06	3.95e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—BCHE—kidney cancer	2.69e-06	3.91e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—KDR—kidney cancer	2.68e-06	3.9e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.67e-06	3.88e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.67e-06	3.88e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—SLC5A5—kidney cancer	2.66e-06	3.87e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.65e-06	3.86e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—CYP1A1—kidney cancer	2.65e-06	3.85e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—GSTT1—kidney cancer	2.64e-06	3.84e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—ACHE—kidney cancer	2.64e-06	3.84e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—GSTM1—kidney cancer	2.64e-06	3.84e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—VEGFA—kidney cancer	2.63e-06	3.83e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—GSTP1—kidney cancer	2.63e-06	3.83e-05	CbGpPWpGaD
Estradiol—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	2.62e-06	3.81e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—GSTP1—kidney cancer	2.62e-06	3.81e-05	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—PTGS2—kidney cancer	2.59e-06	3.77e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—SLC2A1—kidney cancer	2.57e-06	3.73e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—POMC—kidney cancer	2.54e-06	3.69e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—SCARB1—kidney cancer	2.5e-06	3.64e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.49e-06	3.62e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—MAPK3—kidney cancer	2.49e-06	3.62e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—ABCB1—kidney cancer	2.49e-06	3.62e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—ABCB1—kidney cancer	2.48e-06	3.6e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PTGS1—kidney cancer	2.47e-06	3.6e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—APC—kidney cancer	2.47e-06	3.6e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—KIT—kidney cancer	2.47e-06	3.6e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PSMD7—kidney cancer	2.43e-06	3.53e-05	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—PTEN—kidney cancer	2.42e-06	3.52e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—GSTM1—kidney cancer	2.42e-06	3.52e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—PTGS2—kidney cancer	2.41e-06	3.51e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—GSTM1—kidney cancer	2.4e-06	3.5e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—CRABP1—kidney cancer	2.4e-06	3.5e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.38e-06	3.47e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—PTGS2—kidney cancer	2.37e-06	3.45e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—MAPK1—kidney cancer	2.37e-06	3.45e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—POMC—kidney cancer	2.35e-06	3.42e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—GSTP1—kidney cancer	2.35e-06	3.42e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—BRAF—kidney cancer	2.32e-06	3.38e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—BCHE—kidney cancer	2.3e-06	3.35e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—GSTP1—kidney cancer	2.29e-06	3.33e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—CYP1A1—kidney cancer	2.29e-06	3.33e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—CYP1A1—kidney cancer	2.28e-06	3.32e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—SLC5A5—kidney cancer	2.27e-06	3.3e-05	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—PTEN—kidney cancer	2.26e-06	3.28e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—KRAS—kidney cancer	2.24e-06	3.26e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—ITPR2—kidney cancer	2.23e-06	3.25e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—ABCB1—kidney cancer	2.22e-06	3.23e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—PTGS2—kidney cancer	2.2e-06	3.2e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—SLC2A1—kidney cancer	2.19e-06	3.19e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—PTGS2—kidney cancer	2.18e-06	3.17e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—PTGS2—kidney cancer	2.17e-06	3.16e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.17e-06	3.16e-05	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—PIK3CA—kidney cancer	2.17e-06	3.16e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—GSTM1—kidney cancer	2.16e-06	3.14e-05	CbGpPWpGaD
Estradiol—ESR1—Gene Expression—MAPK3—kidney cancer	2.15e-06	3.13e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—GSTP1—kidney cancer	2.14e-06	3.11e-05	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—PIK3CA—kidney cancer	2.13e-06	3.1e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.13e-06	3.1e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—GSTM1—kidney cancer	2.11e-06	3.06e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—PTEN—kidney cancer	2.11e-06	3.06e-05	CbGpPWpGaD
Estradiol—ESR1—Gene Expression—MYC—kidney cancer	2.09e-06	3.04e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—PTEN—kidney cancer	2.07e-06	3.01e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—PIK3CA—kidney cancer	2.06e-06	2.99e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.05e-06	2.99e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—CYP1A1—kidney cancer	2.05e-06	2.98e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—ACHE—kidney cancer	2.04e-06	2.96e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—GSTT1—kidney cancer	2.04e-06	2.96e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—ABCB1—kidney cancer	2.03e-06	2.95e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—PTGS2—kidney cancer	2.03e-06	2.95e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—CYP1A1—kidney cancer	2e-06	2.9e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—TP53—kidney cancer	1.99e-06	2.89e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—POMC—kidney cancer	1.97e-06	2.87e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—GSTM1—kidney cancer	1.97e-06	2.86e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—RAF1—kidney cancer	1.94e-06	2.82e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—RELA—kidney cancer	1.93e-06	2.81e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—SCARB1—kidney cancer	1.93e-06	2.81e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—ERBB2—kidney cancer	1.92e-06	2.79e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—PTEN—kidney cancer	1.92e-06	2.79e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PTGS1—kidney cancer	1.91e-06	2.78e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—PTEN—kidney cancer	1.9e-06	2.76e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—PTEN—kidney cancer	1.9e-06	2.76e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—MTOR—kidney cancer	1.89e-06	2.76e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.88e-06	2.74e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.87e-06	2.72e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PSMD7—kidney cancer	1.87e-06	2.72e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—CYP1A1—kidney cancer	1.87e-06	2.71e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—POMC—kidney cancer	1.86e-06	2.71e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.86e-06	2.7e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—GSTP1—kidney cancer	1.83e-06	2.66e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CDKN1B—kidney cancer	1.78e-06	2.59e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—BCHE—kidney cancer	1.78e-06	2.58e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—PTEN—kidney cancer	1.77e-06	2.57e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—SLC5A5—kidney cancer	1.75e-06	2.55e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—IL2—kidney cancer	1.74e-06	2.53e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—ABCB1—kidney cancer	1.73e-06	2.52e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—POMC—kidney cancer	1.71e-06	2.49e-05	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—PIK3CA—kidney cancer	1.71e-06	2.48e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—POMC—kidney cancer	1.7e-06	2.47e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CCND1—kidney cancer	1.7e-06	2.47e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.69e-06	2.46e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—JUN—kidney cancer	1.69e-06	2.46e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—GSTM1—kidney cancer	1.68e-06	2.45e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.68e-06	2.44e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CTNNB1—kidney cancer	1.68e-06	2.44e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—PTEN—kidney cancer	1.64e-06	2.38e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—CYP1A1—kidney cancer	1.59e-06	2.32e-05	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—PIK3CA—kidney cancer	1.59e-06	2.32e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—PTGS2—kidney cancer	1.57e-06	2.29e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.53e-06	2.23e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—POMC—kidney cancer	1.53e-06	2.22e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—POMC—kidney cancer	1.49e-06	2.17e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—PTGS2—kidney cancer	1.49e-06	2.16e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—PIK3CA—kidney cancer	1.49e-06	2.16e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—VEGFA—kidney cancer	1.48e-06	2.15e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—PIK3CA—kidney cancer	1.46e-06	2.12e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—GSTP1—kidney cancer	1.41e-06	2.05e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—MAPK3—kidney cancer	1.4e-06	2.03e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—POMC—kidney cancer	1.39e-06	2.02e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—PTEN—kidney cancer	1.37e-06	2e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PTGS2—kidney cancer	1.36e-06	1.98e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—MYC—kidney cancer	1.36e-06	1.98e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—PTGS2—kidney cancer	1.36e-06	1.97e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—PIK3CA—kidney cancer	1.35e-06	1.97e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—PIK3CA—kidney cancer	1.34e-06	1.95e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—PIK3CA—kidney cancer	1.34e-06	1.95e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—ABCB1—kidney cancer	1.34e-06	1.94e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—MAPK1—kidney cancer	1.33e-06	1.94e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.31e-06	1.91e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—GSTM1—kidney cancer	1.3e-06	1.89e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—PTEN—kidney cancer	1.3e-06	1.89e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—KRAS—kidney cancer	1.26e-06	1.83e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—PIK3CA—kidney cancer	1.25e-06	1.81e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.23e-06	1.79e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PTGS2—kidney cancer	1.22e-06	1.77e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PTEN—kidney cancer	1.19e-06	1.73e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—POMC—kidney cancer	1.19e-06	1.73e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PTGS2—kidney cancer	1.19e-06	1.73e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—PTEN—kidney cancer	1.18e-06	1.72e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—PIK3CA—kidney cancer	1.15e-06	1.68e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—TP53—kidney cancer	1.12e-06	1.62e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PTGS2—kidney cancer	1.11e-06	1.61e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PTEN—kidney cancer	1.06e-06	1.54e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PTEN—kidney cancer	1.04e-06	1.51e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—PIK3CA—kidney cancer	9.68e-07	1.41e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PTEN—kidney cancer	9.68e-07	1.41e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PTGS2—kidney cancer	9.48e-07	1.38e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—POMC—kidney cancer	9.17e-07	1.33e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—PIK3CA—kidney cancer	9.15e-07	1.33e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PIK3CA—kidney cancer	8.39e-07	1.22e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—PIK3CA—kidney cancer	8.34e-07	1.21e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PTEN—kidney cancer	8.27e-07	1.2e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PIK3CA—kidney cancer	7.49e-07	1.09e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PTGS2—kidney cancer	7.32e-07	1.06e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PIK3CA—kidney cancer	7.31e-07	1.06e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PIK3CA—kidney cancer	6.83e-07	9.93e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PTEN—kidney cancer	6.38e-07	9.28e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PIK3CA—kidney cancer	5.83e-07	8.48e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PIK3CA—kidney cancer	4.5e-07	6.55e-06	CbGpPWpGaD
